Ulrike Heberling

Papers

1

Total Citations

2

H-Index

1

About

Ulrike Heberling is a dedicated urological researcher whose work focuses on improving surgical outcomes for prostate cancer patients, particularly through the refinement of robotic-assisted laparoscopic techniques. Her research addresses critical gaps in the understanding of extended pelvic lymph node dissections (ePLND), a procedure essential for accurate cancer staging. In her highly cited study, she meticulously analyzed the lymph node yield and distribution patterns from 5,050 consecutive patients undergoing radical prostatectomy, providing invaluable data that helps surgeons optimize the extent and efficacy of lymph node removal. This large-scale validation work directly contributes to more precise surgical planning and better prognostic accuracy for men with prostate cancer. Beyond this landmark study, Dr. Heberling has also contributed to the development of easily applicable comorbidity indices, demonstrating a commitment to creating practical, patient-centered tools that enhance preoperative risk assessment. Her research, grounded in robust clinical data, has a tangible impact on urological oncology, helping to standardize and improve surgical care for thousands of patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
PD40-07 VALIDATION OF AN EASILY APPLICABLE QUESTIONNAIRE-SUITED COMORBIDITY INDEX IN 5050 CONSECUTIVE PATIENTS UNDERGOING RADICAL PROSTATECTOMY
2 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 8

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago